Stem Cell Research Institute

Name

Stem Cell Research Institute

Legal name

Instituto de Pesquisa com Células-tronco

Website

https://celulastroncors.org.br

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Porto

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Non-commercial / Social Purpose: IPCT is a civil association with social character and no economic purposes, qualified as an OSCIP (Organização da Sociedade Civil de Interesse Público). All treatments and knowledge dissemination are provided free of charge to the community (children, adolescents, elderly, families, and workers). Revenue is not generated from commercial activity; operations are sustained through partnerships with universities, government science councils, and international research funding.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

The Instituto de Pesquisa com Células-tronco (IPCT) is a non-profit civil association (OSCIP) that develops, implements, and disseminates stem cell-based knowledge and treatments through scientific research, educational programs, and clinical application for health promotion and quality of life. It provides free, universal access to stem cell therapies and regenerative medicine to the Brazilian public, while conducting research in tissue engineering, 3D bioprinting, nanotechnology, and bioactive biomaterials for bone and skin regeneration.

Product overview

The Instituto de Pesquisa com Células-tronco (IPCT) is a research institute (associação civil de direito privado) qualified as OSCIP, not a commercial product company. It operates as a nonprofit research organization in partnership with UFRGS focused on stem cell research, tissue engineering, nanotechnology, and regenerative medicine. Its offerings include research services, educational programs (such as the annual MedReg course), scientific conferences, and community outreach initiatives like the 'Juntos pela Vida' stem cell donation awareness program. The institute also conducts funded research projects in biomaterials for bone and skin regeneration using 3D bioprinting and nanotechnology.

Differentiator

Problem solved

Functional benefit

Products and services

• Stem Cell Research Services Research services focused on developing, implementing, and disseminating stem cell-based treatments through research, education, and application for health promotion and quality of life improvement. Targeted at the general Brazilian public, including children, adolescents, elderly, families, and workers, with all treatments provided free of charge.
• Tissue Engineering Research Research in tissue engineering to create human tissue for medical treatments and regenerative applications, including 3D bioprinting of skin and bone constructs at the UFRGS Hematology and Stem Cell Laboratory.
• Regenerative Medicine Treatments Cellular therapy and regenerative medicine treatments aimed at improving health and quality of life. Treatments are provided free and universally to the general public through the Brazilian public health system.
• MedReg Course (Medicina Regenerativa) Annual in-person course promoted by UFRGS with IPCT support, covering regenerative medicine topics and held in Porto Alegre, Rio Grande do Sul. Targets students, researchers, and professionals interested in regenerative medicine.
• Biomaterials for Bone and Cutaneous Regeneration Project Funded research project for the development of medical devices for the treatment of skin wounds and bone injuries using 3D bioprinting, nanotechnology, and stem cell techniques. Coordinated by Dr. Patricia Pranke and funded by the U.S. Office of Naval Research Global (ONRG).
• Bioactive Ceramics for Bone and Skin Regeneration Research program focused on the development and characterization of bioactive ceramics for bone and skin regeneration, including 3D bioprinting bioinks containing decellularized bone marrow and decellularized skin matrices. Conducted at UFRGS under the orientation of Dra. Natasha Maurmann and Prof. Dra. Patricia Pranke.
• Juntos pela Vida (Friends for Life) Program Social outreach program promoting the dissemination of knowledge and awareness about the importance of stem cell donation for public health, targeting the Brazilian community.

Quantifiable outcome

• 4 international conferences organized on Tissue Engineering and Regenerative Medicine
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Universidade Federal do Rio Grande do Sul (UFRGS)coreStrategic or Co-development PartnerIPCT operates in formal partnership with the Faculdade de Farmácia (School of Pharmacy) and the Instituto de Ciências Básicas da Saúde (ICBS) of UFRGS. Activities are conducted at UFRGS laboratories including the Hematology and Stem Cell Laboratory. Dr. Patricia Pranke serves as both IPCT Coordinator and UFRGS Vice-Rector, and IPCT is registered with the municipal council of Porto Alegre.
• Rede NanoSaúde (NanoSaúde Network)minorStrategic or Co-development PartnerIPCT participates in the NanoSaúde Network, a Brazilian research network promoting nanotechnology applications in health. Dr. Patricia Pranke was a keynote speaker at the 3rd NanoSaúde Network Workshop held at the Centro Brasileiro de Pesquisas Físicas in July 2025.
• SOBRACEL (Sociedade Brasileira de Terapia Celular e Medicina Regenerativa)coreStrategic or Co-development PartnerIPCT is affiliated with SOBRACEL, the Brazilian Society of Cell Therapy and Regenerative Medicine. Dr. Patricia Pranke received the Prêmio Mérito Científico Raul Canal at SOBRACEL's 1st International Congress in June 2024.
• ANADEM (Sociedade Brasileira de Direito Médico e Bioética)minorOthersAwarding body that granted Dr. Patricia Pranke the Medalha Wilmes Teixeira, its highest honor recognizing exceptional contributions to science.
• UFRGS Portas AbertasminorOthersIPCT participates in UFRGS's annual community open-door event, presenting interactive workshops on stem cell science to the general public and inspiring future students.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Mesoblast: Commercial regenerative medicine company developing cellular therapies for inflammatory and cardiovascular conditions; comparable to IPCT in underlying science (cell-based regenerative therapies) but operates as a for-profit, clinical-stage biotech with regulatory and commercialization capabilities IPCT lacks.
• Pluristem Therapeutics: Cell therapy company using placenta-derived cells for regenerative indications; comparable to IPCT in cell-therapy orientation and broad regenerative medicine mandate, but commercially structured versus IPCT's non-profit research model.
• Athersys: Clinical-stage cell therapy company developing MultiStem for inflammatory, neurological, and cardiovascular conditions; comparable to IPCT in regenerative medicine and stem cell-derived therapeutic focus, but operates through clinical trials and commercial partnerships globally.

Emerging players

• Cynata Therapeutics: Clinical-stage stem cell company developing iPSC-derived mesenchymal stem cell therapies; comparable to IPCT in stem cell platform orientation and broad regenerative indications, but at clinical/commercial stage rather than research-stage.
• BrainStorm Cell Therapeutics: Cell therapy company developing autologous MSC-based therapies for neurodegenerative diseases; comparable to IPCT in cell-therapy R&D orientation, with narrower indication focus (ALS, MS) and commercial vs. non-profit structure.
• ViaCyte: Regenerative medicine company developing stem cell-derived islet cell replacement therapies for type 1 diabetes; comparable to IPCT in stem-cell-derived regenerative approach and tissue engineering orientation, but commercial and indication-specific.

Direct peers

• New York Stem Cell Foundation: Non-profit research organization advancing stem cell research and translating findings into therapies; comparable to IPCT as a mission-driven stem cell research body, though NYSCF operates at much larger scale and with independent laboratory infrastructure rather than embedding in a host university.
• Harvard Stem Cell Institute: University-affiliated, multi-disciplinary stem cell and regenerative biology research institute; directly comparable to IPCT in focus areas (stem cells, regenerative medicine) and academic-partnership model, although operating at significantly greater scale and funding base.
• Karolinska Institutet - Cell and Molecular Research: Medical university conducting stem cell and regenerative medicine research with policy influence through Nobel Assembly ties; comparable to IPCT in academic integration and biomedical research depth, with global prestige in regenerative medicine.
• Wellcome-MRC Cambridge Stem Cell Institute: University-based stem cell research institute combining basic and translational research; closely comparable to IPCT in mandate and academic embedding, with broader disease-area coverage and larger international funding base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@institutodepesquisacomcelu922
• Facebookfacebook.com/celulastronco
• Instagraminstagram.com/celulastroncoipct

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stem Cell Research Institute